Edition:
United Kingdom

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

882.45INR
11:29am BST
Change (% chg)

Rs2.20 (+0.25%)
Prev Close
Rs880.25
Open
Rs885.00
Day's High
Rs893.45
Day's Low
Rs876.20
Volume
1,526,383
Avg. Vol
3,429,647
52-wk High
Rs1,090.00
52-wk Low
Rs723.65

Select another date:

Wed, Aug 8 2018

UPDATE 1-India's Lupin Q1 profit misses estimate by wide margin

Aug 8 Drugmaker Lupin Ltd posted a bigger-than-expected fall in first-quarter profit on Wednesday, hurt by declining sales in the United States and Japan.

India's Lupin quarterly profit falls 43 pct

Aug 8 Drugmaker Lupin Ltd posted a 43 percent fall in first-quarter profit on Wednesday, widely missing analysts' estimates.

BRIEF-Omeros Says Entered Into Settlement Agreement And Consent Judgment With Lupin Ltd and unit Lupin Pharmaceuticals - SEC Filing

* OMEROS SAYS ENTERED INTO SETTLEMENT AGREEMENT AND CONSENT JUDGMENT WITH LUPIN LTD, SUBSIDIARY LUPIN PHARMACEUTICALS - SEC FILING

UPDATE 2-India's Lupin expects U.S. drug pricing pressure to ease in 2019

* U.S. sales fall 21.1 pct; India sales up 14 pct (Adds management comments from conference call)

India's Lupin posts surprise Q4 loss on one-time charge

May 15 Lupin Ltd, India's second-largest drugmaker by revenue, reported a surprise loss in its fiscal fourth quarter on Tuesday, due to a one-time charge.

BRIEF-India's Lupin Gets FDA Approval For Generic Temovate Ointment, 0.05 Percent

* GETS FDA APPROVAL FOR GENERIC TEMOVATE OINTMENT, 0.05 PERCENT

BRIEF-India's Lupin Gets FDA Nod For Generic Xenazine Tablets, 12.5 Mg And 25 Mg

* SAYS CO RECEIVES FDA APPROVAL FOR GENERIC XENAZINE TABLETS, 12.5 MG AND 25 MG Source text - http://bit.ly/2qUd2T4 Further company coverage:

Select another date: